Further mechanistic studies in such tumor cells are also challenged by the high frequency of concurrent TERT copy number variations, promoter polymorphisms, and cancer-associated dysregulation of factors implicated in TERT regulation such as MYC. The gene discussed is MYC; the disease is neoplasm.